Affiliation:
1. Università degli Studi di Milano
2. Istituto Clinico Città Studi
Abstract
Abstract
Background
Evidence showed the role of biomarkers in predicting severity and mortality of coronavirus disease 2019 (COVID-19). We evaluated associations between several biomarkers measured throughout the follow-up and COVID-19 mortality using the joint modelling (JM) approach, the candidate tool for this kind of data.
Methods
Between February and May 2020, a total of 403 COVID-19 patients were admitted. Baseline characteristics included sex and age, whereas biomarkers included lymphocytes, neutrophils, D-dimer, ferritin, C-reactive protein, glucose and lactate dehydrogenase (LDH). Hazard ratios (HR) and 95% confidence interval (CI) were estimated through JM using a Bayesian approach. We fitted univariable and multivariable JMs including a single biomarker and the set of all biomarkers, respectively.
Results
In univariable JMs, all biomarkers were significantly associated with COVID-19 mortality. In the multivariable JM, HRs were 1.78 (95% CI: 1.13–2.87) per doubling of neutrophils levels, 1.49 (95% CI: 1.19–1.95) per doubling of C-reactive protein levels, 2.66 (95% CI: 1.45–4.95) per an increase of 100 mg/dL of glucose, and 1.31 (95% CI: 1.12–1.55) per an increase of 100 U/L of LDH. No evidence of association was observed for ferritin and lymphocytes in the multivariable JM. Men had a higher risk of COVID-19 mortality than women (HR = 1.75; 95% CI: 1.07–2.80) and age showed the strongest effect with risk starting to rapidly increase from 60 years.
Conclusions
These findings using JM confirm the usefulness of biomarkers in assessing COVID-19 severity and mortality. Monitoring trend patterns of such biomarkers can provide additional help in tailoring the more appropriate care pathway.
Publisher
Research Square Platform LLC
Reference69 articles.
1. World Health Organization (WHO). Coronavirus disease (COVID-19) weekly epidemiological update and weekly operational update. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---12-april-2022. Accessed 14th April 2022. 2022.
2. Risk factors for severe and critically ill COVID-19 patients: A review;Gao YD;Allergy,2021
3. Zhang JJ, Dong X, Liu GH, Gao YD. Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality.Clin Rev Allergy Immunol. 2022.
4. Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies;Pijls BG;BMJ Open,2021
5. Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission;Lighter J;Clin Infect Dis,2020